¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"resistance form"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • resistance amplification
    ÀúÇ×ÁõÆø
  • resistance coil
    ÀúÇ×ÄÚÀÏ
  • resistance factor
    ³»¼ºÀÎÀÚ, ÀúÇ×ÀÎÀÚ
  • resistance furnace
    ÀúÇ×·Î
  • resistance plasmid
    ÀúÇ×Çö󽺹̵å
  • resistance reflex
    ÀúÇ׹ݻç
  • resistance transfer factor
    ³»¼ºÀü´ÞÀÎÀÚ
  • respiratory resistance
    È£ÈíÀúÇ×
  • vascular resistance
    Ç÷°üÀúÇ×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • peripheral vascular resistance
    ¸»ÃÊÇ÷°üÀúÇ×
  • pleiotropic resistance
    ´Ù¸é¹ßÇö¼ºÀúÇ×
  • progressive resistance
    Á¡ÁõÀúÇ×
  • pulmonary flow resistance
    Æó±â·ùÀúÇ×
  • pulmonary vascular resistance
    ÇãÆÄÇ÷°üÀúÇ×, ÆóÇ÷°üÀúÇ×
  • resistance plasmid
    ÀúÇ×Çö󽺹̵å
  • resistance
    ³»¼º, ÀúÇ×, ÀúÇ×¼º
  • radiation resistance
    ¹æ»ç¼±ÀúÇ×
  • residual resistance
    ÀÜ·ùÀúÇ×
  • resistance reflex
    ÀúÇ׹ݻç
  • respiratory resistance
    È£ÈíÀúÇ×
  • shock resistance
    ¼îÅ©³»¼º
  • specific resistance
    ƯÀÌÀúÇ×
  • total peripheral resistance
    ÃѸ»ÃÊÀúÇ×, Àüü¸»ÃÊÀúÇ×
  • total pulmonary resistance
    (¢¡pulmonary vascular) ÇãÆÄÇ÷°üÀúÇ×, ÆóÇ÷°üÀúÇ×
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • rough form
    RÇü(¡­úþ).
  • stable L-form
    ¾ÈÁ¤µÈ L-Çü[¼¼]±Õ
  • star form
    º°Çü(ÊÙÌ´).
  • subperiodic form
    ÁØÁÖ±âÇü(ñÞñÎÑ¢û¡).
  • subperiodic form
    ÁØÁÖ±âÇü(ñÞñÎÑ¢û¡)
  • tissue form
    Á¶Á÷Çü
  • tissue form
    Á¶Á÷Çü(ðÚòÄû¡)
  • transitional form
    ÀÌÇàÇü(ì¹ú¼û¡)
  • undercut form
    ÷¿ÍÇüÅÂ(ôÕèÀû¡÷¾).
  • undissociated form
    ºñÇØ¸®Çü.
  • variant form
    ÀÌÇü(ì¶úþ).
  • variant form
    ÀÌÇü(ì¶úþ)
  • variations of form
    Çüź¯ÀÌ
  • vegetative form
    ¿µ¾çÇü(ç½å×û¡).
  • vegetative form
    ¿µ¾çÇü(ç½å×û¡).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
cDGS complete form of DiGeorge syndrome
CEEF clinical evaluation encounter form
CKS classic form of Kaposi sarcoma
CRF case report form; chronic renal failure; chronic respiratory failure; coagulase-reacting factor; con...
CTMM-SF California Test of Mental Maturity-Short Form
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CRF circulating recombinant form
GST-P+ glutathione S-transferase placental form positive
iNOS inducible form of .NO synthase
iNOS inducible form of NOS
iNOS inducible form of nitric oxide synthase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • large surface form
    ³ÐÀº ¸éÀÇ ÇüÅÂ
  • lethal form
    Ä¡»çÀûÀÎ ÇüÅÂ
  • liquid form
    ¾×ü »óÅÂ
    ¹°À̳ª ±â¸§°ú °°ÀÌ ÀÚÀ¯·ÎÀÌ À¯µ¿ÇÏ¿© ¿ë±âÀÇ ¸ð¾ç¿¡ µû¶ó ±× ¸ð¾çÀÌ º¯Çϸç ÀÏÁ¤ÇÑ ÇüŸ¦ °¡ÁöÁö ¾Ê°í ¾ÐÃàÇØµµ °ÅÀÇ ºÎÇǰ¡ º¯ÇÏÁö ¾Ê´Â ¹°Áú. Á¤È®È÷´Â ¾×ü »óŶó°í ÇÑ´Ù. ¼ö¸¹Àº ¹°Áú °¡¿îµ¥ »ó¿Â, »ó¾Ð¿¡¼­ ÀÌ¿Í °°Àº »óŸ¦ °¡Áö´Â °ÍÀº ºñ±³Àû ÀûÀ¸³ª, Àû´çÇÑ ¿Âµµ¿Í ¾Ð·ÂÀÇ Á¶°ÇÀÌ °®Ãß¾îÁö¸é °ÅÀÇ ¸ðµç ¹°ÁúÀÌ ¾×ü·Î º¯ÇÒ ¼ö ÀÖÀ¸¸ç, ¹Ý´ë·Î ¾×üµµ ´Ù½Ã ±âü³ª °íü·Î º¯ÇÒ ¼ö ÀÖ´Ù. Áï, ¾×ü¶ó´Â °ÍÀº ¹°Áú¿¡ °íÀ¯ÇÑ ¼ºÁúÀÌ ¾Æ´Ï¶ó Á¶°Ç¿¡ µû¶ó¼­ ±âü·Îµµ °íü·Îµµ º¯ÇÒ ¼ö ÀÖ´Â ¹°ÁúÀÇ Á¸Àç »óÅÂÀÇ Çϳª¿¡ ºÒ°úÇÏ´Ù. ÀÌ·± ¶æ¿¡¼­ °íü»ó, ±âü»ó¿¡ ´ëÇØ¼­ ¾×ü»óÀ̶ó°í ÇÏ´Â °æ¿ìµµ ÀÖ´Ù. ¶ÇÇÑ ÇϳªÀÇ ¹°ÁúÀÌ °íü¿¡¼­ ¾×ü·Î º¯È­ÇÏ´Â Çö»óÀ» À¶ÇØ, ¾×ü¸é¿¡¼­ ±âÈ­ÇÏ´Â °ÍÀ» Áõ¹ßÀ̶ó°í Çϳª, ±âÈ­´Â ¾×ü ³»ºÎ¿¡¼­µµ ÀϾ¸ç, ¾×ü°¡ Àü¸éÀûÀ¸·Î ±âü·Î º¯ÇÏ´Â Çö»óÀ» ºñµîÀ̶ó°í ÇÑ´Ù. ÀÏÁ¤ÇÑ ¾Ð·ÂÇÏ¿¡¼­ÀÇ
  • localized form
    ±¹¼Ò Çü
  • marginal form
    ¿Ü¿¬ ÇüÅÂ, º¯¿¬ ÇüÅÂ
  • mixed form
    È¥ÇÕ Çü
  • occlusal form
    ±³ÇÕ ÇüÅÂ
    Ä¡¾Æ³ª Ä¡¿­ÀÇ ±³ÇÕ¸éÀÇ ÇüÅÂ.
  • outline form of cavity
    ¿Íµ¿ ¿ÜÇü
    ¿Íµ¿ÀÇ ÇüÅ¿¡´Â ¿Íµ¿ ¿ÜÇü, À¯Áö ÇüÅÂ, ÀúÇ× ÇüÅÂ, ÆíÀÇ ÇüÅÂ¿Í °°ÀÌ 4Á¾·ù°¡ Àִµ¥ ¿Íµ¿ ¿ÜÇüÀ̶õ ¿Íµ¿ Çü¼º¿¡ À־ °¡Àå ±âº»ÀÌ µÇ´Â °ÍÀ¸·Î ¿Íµ¿ ¿ÜÇüÀº ¾ðÁ¦³ª °ÇÀüÇÑ ¹ý¶ûÁú »ó¿¡ ¼³Á¤µÇ¾î¾ß ÇÏ¸ç ¿¹¹æ È®´ë°¡ ÃæºÐÇÏ¿©¾ß Çϸç, Çü¼ºµÈ ¿Íµ¿ÀÇ cave surface angle³»¿¡ Æ÷ÇԵǾîÁö´Â Ä¡¸éÀÇ ¿ÜÇüÀ» ¸»ÇÑ´Ù.
  • registration of functional form
    ±â´É ÇüÅ Àαâ
  • retention form of cavity
    ¿Íµ¿ÀÇ À¯Áö ÇüÅÂ
  • root form endosteal implant
    Ä¡±ÙÇü °ñ³» ÀÓÇöõÆ®
  • spherical form of occlusion
    ±³ÇÕ ±¸¸é, ±³ÇÕÀÇ ±¸¸é
    Ä¡¾ÆÀÇ ¼öÆò¸é À§¿¡ Áß½ÉÀ» °¡Áø °¡»ó±¸.
  • systemic form
    Àü½Å ÇüÅÂ
  • treatment outcome form
    Ä¡·á °á°ú Æò°¡Ç¥
  • ulcerated form
    ±Ë¾ç ÇüÅÂ
    ±Ë¾çÀÇ ¸ð½À°ú ºñ½ÁÇÑ, ¹é»ö ¶Ç´Â Ȳ°¥»öÀÇ ¼¶À¯¼Ò ÀÀ±«·Î µ¤¿© ÀÖ´Â ¸ð¾ç.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
resistance-transfer factor The transfer gene of the resistance plasmid.
(05 Mar 2000)
resistance-transferring episomes Plasmid's carrying genes responsible for antibiotic (or antibacterial drug) resistance among bacteria (notably Enterobacteriaceae); they may be conjugative or nonconjugative plasmid's, the former possessing transfer genes (resistance transfer factor) lacking in the latter.
Synonym: R factors, R plasmids, resistance factors, resistance-transferring episomes.
(05 Mar 2000)
resistance, vascular The opposition to the flow of blood across a vascular bed.
(12 Dec 1998)
cephalosporin resistance <microbiology> Non-susceptibility of an organism to the action of the cephalosporins.
(12 Dec 1998)
penicillin resistance <microbiology, pharmacology> Nonsusceptibility of an organism to the action of penicillins.
(12 Dec 1998)
peripheral resistance The total resistance to flow of blood in the systemic circuit; the quotient produced by dividing the mean arterial pressure by the cardiac minute-volume.
Synonym: peripheral resistance.
(05 Mar 2000)
chloramphenicol resistance <microbiology, pharmacology> Nonsusceptibility of a bacterium to the action of chloramphenicol, a potent inhibitor of protein synthesis in the 50s ribosomal subunit where amino acids are added to nascent bacterial polypeptides.
(12 Dec 1998)
methicillin resistance Non-susceptibility of a microbe to the action of methicillin, a semi-synthetic penicillin derivative.
(12 Dec 1998)
multidrug resistance The insensitivity of various tumours to a variety of chemically related anticancer drugs; mediated by a process of inactivating the drug or removing it from the target tumour cells.
(05 Mar 2000)
mutual resistance An interaction between chemicals in which one partially or completelyinhibits the effect of the other (for example, a drug that blocks a hormone's receptor site would be a hormone antagonist).
(09 Oct 1997)
cross-resistance <immunology, microbiology> Immunologic resistance to the pathogenic effects of a microorganism because of previous exposure to another species or type having cross reactive antigens.
This phenomenon is seen in microbes that acquire resistance to one drug through direct exposure and turn out to have resistance to one or more other drugs to which it has not been exposed. Cross-resistance arises because the mechanism of resistance to several drugs is the same and arises through the identical genetic mutations.
(09 Oct 1997)
sisomicin-gentamicin resistance ribosomal RNA methylase <enzyme> Catalyses the methylation of 30s ribosomal units to confer sisomicin-gentamicin resistance in micromonospora zionensis
Registry number: EC 2.1.1.-
Synonym: sgm gene product, sgm methylase
(26 Jun 1999)
synaptic resistance The ease or difficulty with which a nerve impulse can cross a synapse.
(05 Mar 2000)
systemic vascular resistance An index of arteriolar compliance or constriction throughout the body; equal to the blood pressure divided by the cardiac output.
(05 Mar 2000)
dicumarol resistance A well-defined autosomal dominant resistance to it, over and above general variability in tolerance to the drug.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á